MCL1 and neuroblastoma: To evaluate the role of CNAs in survival of neuroblastoma patients and whether activation of MCL1 through 1q21 gain also plays a role in neuroblastoma patient prognosis, the association between the presence of gains and losses and survival was determined using Cox regression in two independent datasets [34, 35].